Paper6692385
Phase I study of the plant protein ricin.
Fodstad O and 6 others. Cancer Res, 1984. Cited by 69 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Phase I study of the plant protein ricin. Papers, record 6692385. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/6692385
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics14
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Neoplasms | Major topic |
| Ricin | Major topic |
| Abrin | |
| Adolescent | |
| Adult | |
| Aged | |
| Antibody Formation | |
| Drug Evaluation | |
| Female | |
| Half-Life | |
| Humans | |
| Lymphoma | |
| Male | |
| Middle Aged |
Source PubMed
Cited by18
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 69 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 36,140,189 | Ribosome-Directed Therapies in Cancer. | Biomedicines | 2022 | https://conductscience.org/library/papers/36140189 | PubMed |
| 34,067,057 | Natural and Designed Toxins for Precise Therapy: Modern Approaches in Experimental Oncology. | Int J Mol Sci | 2021 | https://conductscience.org/library/papers/34067057 | PubMed |
| 32,182,799 | Engineering of Ribosome-inactivating Proteins for Improving Pharmacological Properties. | Toxins (Basel) | 2020 | https://conductscience.org/library/papers/32182799 | PubMed |
| 31,359,089 | Ricin and Ricinus communis in pharmacology and toxicology-from ancient use and "Papyrus Ebers" to modern perspectives and "poisonous plant of the year 2018". | Naunyn Schmiedebergs Arch Pharmacol | 2019 | https://conductscience.org/library/papers/31359089 | PubMed |
| 31,313,388 | Sensitivity of Kupffer cells and liver sinusoidal endothelial cells to ricin toxin and ricin toxin-Ab complexes. | J Leukoc Biol | 2019 | https://conductscience.org/library/papers/31313388 | PubMed |
| 31,216,687 | Intracellular Transport and Cytotoxicity of the Protein Toxin Ricin. | Toxins (Basel) | 2019 | https://conductscience.org/library/papers/31216687 | PubMed |
| 26,349,746 | Potential therapeutic applications of plant toxin-ricin in cancer: challenges and advances. | Tumour Biol | 2015 | https://conductscience.org/library/papers/26349746 | PubMed |
| 23,692,086 | Molecular mechanisms of Lycoris aurea agglutinin-induced apoptosis and G2 /M cell cycle arrest in human lung adenocarcinoma A549 cells, both in vitro and in vivo. | Cell Prolif | 2013 | https://conductscience.org/library/papers/23692086 | PubMed |
| 22,872,642 | Evaluation of riproximin binding properties reveals a novel mechanism for cellular targeting. | J Biol Chem | 2012 | https://conductscience.org/library/papers/22872642 | PubMed |
| 22,327,430 | Immunotoxins constructed with chimeric, short-lived anti-CD22 monoclonal antibodies induce less vascular leak without loss of cytotoxicity. | MAbs | 2012 | https://conductscience.org/library/papers/22327430 | PubMed |
| 20,185,574 | Ricinus communis agglutinin I leads to rapid down-regulation of VEGFR-2 and endothelial cell apoptosis in tumor blood vessels. | Am J Pathol | 2010 | https://conductscience.org/library/papers/20185574 | PubMed |
| 12,952,291 | Immunotoxin therapy for CNS tumor. | J Neurooncol | 2003 | https://conductscience.org/library/papers/12952291 | PubMed |
| 6,488,437 | Pharmacological studies of ricin in mice and humans. | Cancer Chemother Pharmacol | 1984 | https://conductscience.org/library/papers/6488437 | PubMed |
| 3,543,527 | Immunotoxin therapy of malignant melanoma. | Med Oncol Tumor Pharmacother | 1986 | https://conductscience.org/library/papers/3543527 | PubMed |
| 3,525,471 | Immunocytochemical detection of ricin. II. Further studies using the immunoperoxidase method. | Histochem J | 1986 | https://conductscience.org/library/papers/3525471 | PubMed |
| 2,188,142 | [100 years of lectin research--a balance]. | Naturwissenschaften | 1990 | https://conductscience.org/library/papers/2188142 | PubMed |
| 2,074,894 | [Tumor lectinology--status and perspectives of clinical application]. | Naturwissenschaften | 1990 | https://conductscience.org/library/papers/2074894 | PubMed |
| 2,039,695 | Lymphocyte targeted ricin as a potential therapy for lymphoid malignancy. I. Targeting efficiency. | Br J Cancer | 1991 | https://conductscience.org/library/papers/2039695 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/6692385
GET https://conductscience.org/api/papers/v1/6692385/authors